Related Experiment Video
Updated: Aug 13, 2026

06:37
Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
Published on: October 20, 2010
Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer
Fredrik Liedberg1, Gunilla Chebil, Thomas Davidsson
1Department of Urology, Lund University Hospital, Lund, Sweden. fredrik.liedberg@skane.se
The Journal of Urology
|January 13, 2006
Summary
Sentinel lymph node (SN) detection is feasible in invasive bladder cancer, though the false-negative rate was 19%. This technique improved nodal staging in 25% of patients, identifying micrometastases and additional metastatic SNs.
Area of Science:
- Urology
- Surgical Oncology
- Nuclear Medicine
Background:
- Radical cystectomy with extended lymphadenectomy is standard for invasive bladder cancer.
- Accurate nodal staging is crucial for treatment planning and prognosis.
- Sentinel lymph node (SN) biopsy may improve staging accuracy.
Purpose of the Study:
- To evaluate intraoperative SN detection during radical cystectomy for invasive bladder cancer.
- To assess the feasibility and accuracy of SN identification using combined techniques.
Main Methods:
- 75 patients with invasive bladder cancer underwent radical cystectomy and extended lymphadenectomy.
- SNs were identified using preoperative lymphoscintigraphy, intraoperative dynamic lymphoscintigraphy, and blue dye.
- Isotope ((99m)Tc-nanocolloid) and Patent Blue dye were injected peritumorally.
- Ex vivo examination of excised nodes used a handheld gamma probe, serial sectioning, H&E staining, and immunohistochemistry.
Main Results:
- An SN was identified in 87% of patients (65/75).
- Of 32 lymph node-positive patients, 26 (81%) had a metastatic SN, resulting in a 19% false-negative rate.
- Micrometastases were found in SNs of 9 patients (14%), and radio-guided surgery identified additional SNs in 7 patients.
Conclusions:
- Intraoperative SN detection is feasible in invasive bladder cancer.
- The study demonstrated a 19% false-negative rate, highlighting areas for improvement.
- Combined techniques, including extended serial sectioning and immunohistochemistry, enhanced nodal staging accuracy in 25% of cases.
